The effectiveness of a standardized tobacco cessation program on addiction patients undergoing long-term rehabilitation

The effectiveness of a standardized tobacco cessation program on psychophysiological parameters in addiction patients undergoing long-term rehabilitation: a quasi-experimental pilot study

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN15684371

Enrollment

Registered

2024-03-07

Start date

2022-11-01

Completion date

Unknown

Last updated

2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tobacco addiction in patients diagnosed with Mental and behavioral disorders due to multiple drug use and use of other psychoactive substances, dependence syndrome (F19.2) Mental and Behavioural Disorders

Interventions

This non-randomized interventional study examines the potential benefit of a standardized tobacco cessation program in a group of patients undergoing long-term addiction treatment. An intervention gro

participants in the program) and a control group receiving Treatment As Usual Group (TAUG

non-participants in the program) in an inpatient addiction clinic (single center). The study design was a quasi-experimental controlled trial, without random assignment. None of the participants took

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. voluntary participation 2. a current tobacco dependence (F17.2) 3. a current poly-drug use disorder (F19.2) 4. the desire to quit smoking 5. an age > 18 years.

Exclusion criteria

Exclusion criteria: Does not meet inclusion criteria

Design outcomes

Primary

Measure	Time frame
1. Tobacco dependence is measured by the The Fagerström Test for Cigarette Dependence (FTND) at baseline and 1,5 weeks after the intervention. 2. Smoked cigarettes per day is measured by the The Fagerström Test for Cigarette Dependence (FTND) at baseline and 1,5 weeks after the intervention. 3. Craving is measured by the Mannheim Craving Scale (MaCS) at baseline and 1,5 weeks after the intervention.	—

Measure

Time frame

1. Tobacco dependence is measured by the The Fagerström Test for Cigarette Dependence (FTND) at baseline and 1,5 weeks after the intervention. 2. Smoked cigarettes per day is measured by the The Fagerström Test for Cigarette Dependence (FTND) at baseline and 1,5 weeks after the intervention. 3. Craving is measured by the Mannheim Craving Scale (MaCS) at baseline and 1,5 weeks after the intervention.

—

Secondary

Measure	Time frame
1. Heart Rate Variability is measured using Electrocardiography at baseline and 1,5 weeks after the intervention. 2. Psychiatric Symptoms are measured using the Brief Symptom Inventory (BSI-18) at baseline and 1,5 weeks after the intervention. 3. Self-efficacy is measured using the Self-Efficacy Scale (SWE) at baseline and 1,5 weeks after the intervention.	—

Countries

Austria

Contacts

Public ContactHuman Friedrich Unterrainer

human.unterrainer@sfu.ac.at+43 69918195990

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 8, 2026